Comprehensive Analysis of Gene Mutation Profile in Chinese NSCLC Patients by Next-generation Sequencing
Clinical trial NCT03609918 · COMPLETED
Trial details
- NCT number
- NCT03609918
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-09-27
- Primary completion
- 2017-09-27
- Enrollment
- 513
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.